Xue, Q., Wang, W., Liu, J., Wang, D., Zhang, T., Shen, T., . . . Fang, X. LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target. BMC.
Chicago Style (17th ed.) CitationXue, Qiqi, et al. LRPPRC Confers Enhanced Oxidative Phosphorylation Metabolism in Triple-negative Breast Cancer and Represents a Therapeutic Target. BMC.
MLA (9th ed.) CitationXue, Qiqi, et al. LRPPRC Confers Enhanced Oxidative Phosphorylation Metabolism in Triple-negative Breast Cancer and Represents a Therapeutic Target. BMC.
Warning: These citations may not always be 100% accurate.